Skip to content
DataLookout
Menu

NCT07073794

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

StatusRecruiting
PhasePhase 2
Primary completion (estimated)

At risk: Primary completion moved 33 days later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Aug 27, 2025 to Jan 22, 2026
    • Eligibility criteria expanded, about 35 words
    • Primary and study completion pushed from Aug 27, 2028 to Sep 29, 2028
    • Secondary endpoints: details revised at 5 of 5 entries
  2. Notable Eligibility criteria expanded, about 1 wordv6
  3. Minor Collaborators expanded, about 5 wordsv5
  4. Notable Eligibility criteria expanded, about 64 wordsv4
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jun 19, 2028 to Aug 27, 2028
    • Start date changed from estimate of Sep 1, 2025 to Aug 27, 2025
    • Site details revised
    v3
  6. Notable Eligibility criteria expanded, about 11 wordsv2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Patient rating of overall cancer care experience - CAHPS
Timeframe: Up to 48 weeks
Patient preferences regarding the location of cancer treatment delivery
Timeframe: Up to 48 weeks
Incidence of grade 3+ adverse events (AEs)
Timeframe: Up to 30 days after last dose of study treatment
Acute care visits, emergency room visits, and hospitalizations
Timeframe: Up to 48 weeks
Avoidable acute care visits, emergency room visits and hospitalizations
Timeframe: Up to 48 weeks

Secondary (5)

Patient-reported function and global health status/quality of life
Patient-reported symptoms as measured by Patient Reported Outcomes (PRO)-CTCAE
Patient-reported symptoms as measured by Functional Assessment of Cancer Therapy General Population 5 (FACT GP5)
Patient Satisfaction and Feedback Questionnaire
Patient satisfaction - Was It Worth It Questionnaire

Arms and interventions

Treatment (in clinic treatment, in home treatment)Experimental

Patients receive standard of care treatment in the clinic for 6-12 weeks then receive treatment in the home with CCBW for 12-24 weeks in the absence of disease progression or unacceptable toxicity. Patients receive any remaining treatment in the clinic.

Drugs: Cancer Therapeutic Procedure

Other: Health Care Delivery, Questionnaire Administration

Sites

1 site in 1 country

  • Mayo Clinic in FloridaJacksonville, Florida, United States